Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Truist Financial Corp decreased its stake in shares of Nevro Corp. (NYSE:NVRO – Get Rating) by 19.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,947 shares of the medical equipment provider’s stock after selling 5,368 shares during the period. Truist Financial Corp owned 0.07% […]
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Nevro (NYSE:NVRO – Get Rating) and IceCure Medical (NASDAQ:ICCM – Get Rating) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Analyst Recommendations This is a breakdown of recent recommendations and price […]
Brokerages expect Nevro Corp. (NYSE:NVRO – Get Rating) to announce $104.66 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Nevro’s earnings, with estimates ranging from $104.48 million to $105.10 million. Nevro reported sales of $102.33 million during the same quarter last year, which indicates a […]